SODIUM PHENYLBUTYRATE
| Brand name | OLPRUVA |
|---|---|
| Active ingredient | SODIUM PHENYLBUTYRATE |
| Strength | 5GM/PACKET |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2022 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11202767 | October 2036 | use U-3502 |
| 11154521 | October 2036 | product |
| 11433041 | October 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.